HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00376662|
Recruitment Status : Completed
First Posted : September 15, 2006
Last Update Posted : September 15, 2006
|Condition or disease||Intervention/treatment||Phase|
|Osteoporosis||Drug: Hormone Replacement Therapy and Etidronate||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||750 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Official Title:||HRT and/or Etidronate in the Prevention and Treatment of Osteoporosis and Fractures in Post-Menopausal Patients With Asthma Receiving Long-Term Oral and/or Inhaled Glucocorticoids:a Randomised Factorial Trial|
|Study Start Date :||August 1992|
|Study Completion Date :||October 2000|
- New symptomatic fractures, new or worsening morphometric fractures of the throaco-lumbar spine, and changes in bone mineral density.
- Unwanted effects
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00376662
|Department of Chest Medicine, Llandough Hospital|
|Cardiff, Wales, United Kingdom, CF62 2XX|
|Department of Chest Medicine, Llandough Hospital,|
|Cardiff, Wales, United Kingdom, CF64 2XX|
|Study Director:||Roger M Francis, MD||School of Clinical Medical Studies University of Newcastle, UK.|